Carnosine Benefits Children with Autism in New Study

06/12/2019
Autism
Carnosine

Study Title: "Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders."

Number of Participants: 31 Children Diagnosed with Autistic Spectrum Disorder

Length of Study: 8 Weeks

Type of Study: Double-blind, Placebo-controlled Study

Publication: Journal of Child Neurology

Study Result: "After 8 weeks on L-carnosine, children showed statistically significant improvements on the Gilliam Autism Rating Scale (total score and the Behavior, Socialization, and Communication subscales)."

In clinical research, L-carnosine has been found to enhance frontal lobe function and be protective of brain function. This study investigated 31 children with autistic spectrum disorders in an 8-week, double-blinded study.

Children were assessed using the Childhood Autism Rating Scale, the Gilliam Autism Rating Scale, the Expressive and Receptive One-Word Picture Vocabulary tests, and Clinical Global Impressions of Change.

According to researchers:

After 8 weeks on L-carnosine, children showed statistically significant improvements on the Gilliam Autism Rating Scale, and the Receptive One-Word Picture Vocabulary test. Improved trends were noted on other outcome measures.

See Study on PubMed >

Autism

Carnosine